Positive reinforcing effects of RFamide-related peptide-1 in the rat central nucleus of amygdala

Behavioural Brain Research

Volumn 275, Issue , 2014, Pages 101-106

  Lénárd, László ^a,b   Kovács, Anita ^a   Ollmann, Tamás ^a   Péczely, László ^a   Zagoracz, Olga ^a   Gálosi, Rita ^a   László, Kristóf ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Amygdala; NPFF receptor antagonist RF9; Place preference; Reinforcement; RFRP 1

Indexed keywords

ARGINYLPHENYLALANYLAMIDE RELATED PEPTIDE 1; NEUROPEPTIDE FF; PEPTIDE; UNCLASSIFIED DRUG; ADAMANTANE; ADAMANTYLCARBONYL-ARGINYL-PHENYLALANINAMIDE; DIPEPTIDE; NEUROPEPTIDE; RFAMIDE PEPTIDE;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; BRAIN REGION; CELL PROLIFERATION; CENTRAL NUCLEUS (AMYGDALA); CONDITIONED PLACE PREFERENCE TEST; CONTROLLED STUDY; GLIA CELL; HABITUATION; HISTOLOGY; LATERAL AMYGDALA; LOCOMOTION; MALE; NONHUMAN; RAT; REINFORCEMENT; REWARD; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; MICROINJECTION; PHYSIOLOGY; WISTAR RAT;

ADAMANTANE; ANALYSIS OF VARIANCE; ANIMALS; CENTRAL AMYGDALOID NUCLEUS; CONDITIONING, OPERANT; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICROINJECTIONS; NEUROPEPTIDES; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY);

EID: 84907183759     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.08.051     Document Type: Article

References (59)

1. Fukusumi S., Fujii R., Hinuma S. Recent advances in mammalian RFamide peptides: the discovery and functional analyses of PrRP, RFRPs and QRFP. Peptides 2006, 27:1073-1086.
2. Bechtold D.A., Luckman S.M. The role of RFamide peptides in feeding. J. Endocrinol. 2007, 192:3-15.
3. Tsutsui K., Ukena K. Hypothalamic LPXRF-amide peptides in vertebrates: identification, localization and hypophysiotropic activity. Peptides 2006, 27:1121-1129.
4. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., Evans N.A., Schmidt D.B., Buckley P.T., Dytko G.M., Murdock P.R., Milligan G., et al. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J. Biol. Chem. 2000, 275:25965-25971.
5. Panula P., Kalso E., Nieminen M., Kontinen V.K., Brandt A., Pertovaara A. Neuropeptide FF and modulation of pain. Brain Res. 1999, 848:191-196.
6. Pertovaara A., Ostergard M., Anko M.L., Lehti-Koivunen S., Brandt A., Hong W., Korpi E.R., Panula P. RFamide-related peptides signal through the neuropeptide FF receptor and regulate pain-related responses in the rat. Neuroscience 2005, 134:1023-1032.
7. Kampe J., Wiedmer P., Pfluger P.T., Castaneda T.R., Burget L., Mondala H., Kerr J., Liaw C., Oldfield B.J., Tschop M.H., Bagnol D. Effect of central administration of QRFP(26) peptide on energy balance and characterization of a second QRFP receptor in rat. Brain Res. 2006, 1119(1):133-149.
8. Castellano J.M., Tena-Sempere M. Metabolic regulation of kisspeptin. Adv. Exp. Med. Biol. 2013, 784:363-383.
9. Dockray G.J. The expanding family of RF-amide peptides and their effects on feeding behaviour. Exp. Physiol. 2004, 89:229-235.
10. Allard M., Labrouche S., Nosjean A., Laguzzi R. Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat. J. Pharmacol. Exp. Ther. 1995, 274:577-583.
11. Horiuchi J., Saigusa T., Sugiyama N., Kanba S., Nishida Y., Sato Y., Hinuma S., Arita J. Effects of prolactin-releasing peptide microinjection into the ventrolateral medulla on arterial pressure and sympathetic activity in rats. Brain Res. 2002, 958:201-209.
12. Nichols R., Bass C., Demers L., Larsen B., Li E., Blewett N., Converso-Baran K., Russell M.W., Westfall M.V. Structure-activity studies of RFamide-related peptide-1 identify a functional receptor antagonist and novel cardiac myocyte signaling pathway involved in contractile performance. J. Med. Chem. 2012, 55(17):7736-7745.
13. Johnson M.A., Tsutsui K., Fraley G.S. Rat RFamide-related peptide-3 stimulates GH secretion, inhibits LH secretion, and has variable effects on sex behavior in the adult male rat. Horm. Behav. 2007, 51(1):171-180.
14. De Tassigny X.A., Colledge W.H. The role of kisspeptin signaling in reproduction. Physiology 2010, 25:207-217.
15. Telegdy G., Adamik A´. The action of kisspeptin-13 on passive avoidance learning in mice. Involvement of transmitters. Behav. Brain Res. 2013, 243(15):300-305.
16. Kavaliers M., Colwell D.D., Neuropeptide F.F. (FLQPQRFamide) and IgG from neuropeptide FF antiserum affect spatial learning in mice. Neurosci. Lett. 1993, 157:75-78.
17. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., Fujii R., Watanabe T., Kikuchi K., Terao Y., Yano T., Yamamoto T., et al. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat. Cell Biol. 2000, 2:703-708.
18. Smith J.T., Clarke I.J. Gonadotropin inhibitory hormone function in mammals. Trends Endocrinol. Metab. 2010, 21:255-260.
19. Liu Q.Y., Guan X.M., Martin W.J., McDonald T.P., Clements M.K., Jiang Q.P., Zeng Z.Z., Jacobson M., Williams D.L., Yu H., Bomford D., Figueroa D., et al. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J. Biol. Chem. 2001, 276:36961-36969.
20. Kaewwongse M., Takayanagi Y., Onaka T. Effects of RFamide-related peptide (RFRP)-1 and RFRP-3 on oxytocin release and anxiety-related behaviour in rats. J. Neuroendocrinol. 2011, 23:20-27.
21. Yano T., Iijima N., Kakihara K., Hinuma S., Tanaka M., Ibata Y. Localization and neuronal response of RFamide related peptides in the rat central nervous system. Brain Res. 2003, 982:156-167.
22. Engstrom M., Brandt A., Wurster S., Savola J.M., Panula P. Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors. J. Pharmacol. Exp. Ther. PET 2003, 305:825-832.
23. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., Smith K.E., Tamm J.A., Boteju L.W., Lakhlani P.P., Raddatz R., Yao W.J. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J. Biol. Chem. 2000, 275:39324-39331.
24. Simonin F., Schmitt M., Laulin J.P., Laboureyras E., Jhamandas J.H., MacTavish D., Matifas A., Mollereau C., Lauren P., Parmentier M., Kieffer B.L., Bourguignon J.-J., Simonnet G.R. F9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance and paradoxical hyperalgesia. Proc. Natl Acad. Sci. USA 2006, 103:466-471.
25. Davis M., Rainnie D., Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci. 1994, 17:208-214.
26. McGaugh J.L., Introini-Collison I.B., Cahill L.F., Castellano C., Dalmaz C., Parent M.B., et al. Neuromodulatory systems and memory storage: role of the amygdala. Behav. Brain. Res. 1993, 58:81-90.
27. Stamatakis A.M., Sparta D.R., Jennings J.H., McElligott Z.A., Decot H., Stuber G.D. Amygdala and bed nucleus of the stria terminalis circuitry: Implications for addiction-related behaviors. Neuropharmacology 2014, 76:320-328.
28. Luo Y.X., Xue Y.X., Shen H.W., Lu L. Role of amygdala in drug memory. Neurobiol. Learning Memory 2013, 105:159-173.
29. Brown E.E., Fibiger H.C. Differential effects of excitotoxic lesions of the amygdala on cocaine-induced conditioned locomotion and conditioned place preference. Psychopharmacology (Berl) 1993, 113:123-130.
30. O'Dell L.E., Sussman A.N., Meyer K.L., Neisewander J.L. Behavioral effects of psychomotor stimulant infusions into amygdaloid nuclei. Neuropsychopharmacology 1999, 20:591-602.
31. Clinton D.K., Carl M.A. Mesoamygdaloid dopamine neurons differential rates of dopamine turnover in discrete amygdaloid nuclei of the rat. Brain Res. 1987, 416:402-4082.
32. Woodward D.J., Chang J.Y., Janak P., Azarov A., Anstrom K. Mesolimbic neuronal activity across behavioral states. Ann. NY Acad. Sci. 1999, 877:91-112.
33. Wu C.H., Tao P.L., Huang E.Y. Distribution of neuropeptide FF (NPFF) receptors in correlation with morphine-induced reward in the rat brain. Peptides 2010, 31(7):1374-1382.
34. Paxinos G., Watson C.R. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, New York.
35. Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 1998, 56:613-672.
36. Huston J.P., Oitzl M.S. The relationship between reinforcement and memory-parallels in the rewarding and mnemonic effects of the neuropeptide substance P. Neurosci. Biobehav. Rev. 1989, 13:171-180.
37. Holzha¨uer-Oitzl M.S., Boucke K., Huston J.P. Reinforcing properties of substance P in the lateral hypothalamus revealed by conditioned place preference. Pharmacol. Biochem. Behav. 1987, 28:511-515.
38. White N.M. Addictive drugs as reinforcers: multiple partial actions on memory systems. Addictions 1996, 91:921-949.
39. Sara S.J. Retrieval and reconsolidation: toward a neurobiology of remembering. Learn Mem. 2000, 7:73-84.
40. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 1992, 13:177-184.
41. Fallon J.H., Koziell D.A., Moore R.Y. Catecholamine innervation of the basal forebrain, II. Amygdala, suprarhinal cortex and entorhinal cortex. J. Comp. Neurol. 1978, 180:509-532.
42. Caine S.B., Heinrichs S.C., Coffin V.L., Koob G.F. Effects of the dopamine D-1 antagonist, SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 1995, 692:47-56.
43. Fukusumi S., Habata Y., Yoshida H., Iijima N., Kawamata Y., Hosoya M., Fujii R., Hinuma S., Kitada C., Shintani Y., Suenaga M., Onda H., Nishimura O., Tanaka M., Ibata Y., Fujino M. Characteristics and distribution of endogenous RFamide-related peptide-1. Biochim. Biophys. Acta 2001, 1540:221-232.
44. Rizwan M.Z., Porteous R., Herbison A.E., Anderson G.M. Cells expressing RFamide-related peptide-1/3, the mammalian gonadotropin-inhibitory hormone orthologs, are not hypophysiotropic neuroendocrine neurons in the rat. Endocrinology 2009, 150:1413-1420.
45. Gouarderes C., et al. Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: a comparative autoradiographic study. Synapse 2004, 51(4):249-269.
46. Gouarderes C., Faura C.C., Zajac J.M. Rodent strain differences in the NPFF1 and NPFF2 receptor distribution and density in the central nervous system. Brain Res. 2004, 1014(1-2):61-70.
47. Allard M., Zajac J.M., Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience 1992, 49:101-116.
48. Marchand S., Betourne A., Marty V., Daumas S., Halley H., Lassalle J.M., Zajac J.M., Frances B. A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice. Peptides 2006, 27:964-972.
49. Jaszberenyi M., Bagosi Z., Thurzo B., Foldesi I., Szabo G., Telegdy G. Endocrine, behavioral and autonomic effects of neuropeptide AF. Horm. Behav. 2009, 56(1):24-34.
50. Fekete E., Vigh J., Bagi E.E., Lenard L. Gastrin-releasing peptide microinjected into the amygdala inhibits feeding. Brain Res. 2002, 955:55-63.
51. Kertes E., Laszlo K., Berta B., Lenard L. Effects of substance P microinjections into the globus pallidus and central nucleus of amygdala on passive avoidance learning in rats. Behav. Brain Res. 2009, 198:397-403.
52. Kertes E., Laszlo K., Berta B., Lenard L. Positive reinforcing effects of substance P in the rat central nucleus of amygdala. Behav. Brain Res. 2009, 205:307-310.
53. Toth K., Laszlo K., Lukacs E., Lenard L. Intraamygdaloid microinjection of acylated-ghrelin influences passive avoidance learning. Behav. Brain Res. 2009, 202:308-311.
54. Kovacs A., Laszlo K., Galosi R., Toth K., Ollmann T., Peczely L., Lenard L. Microinjections of RFRP-1 in the central nucleus of amygdala decreases food intake in the rat. Brain Res. Bull. 2012, 88(6):9-595.
55. Mouledous L., Barthas F., Zajac J.M. Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice. Neuropeptides 2010, 44:453-456.
56. Fang Q., Wang Y.Q., He F., Guo J., Guo J., Chen Q., et al. Inhibition of Neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist. Regul. Pept. 2008, 147:45-51.
57. Kotlinska J.H., Gibula-Bruzda E., Koltunowska D., Raoof H., Suder P., Silberring J. Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats. Peptides 2012, 33(1):156-163.
58. Schildein S., Agmo A., Huston J.P., Schwarting R.K.W. Intraaccumbens injections of substance P, morphine and amphetamine: effects on conditioned place preference and behavioral activity. Brain Res. 1998, 790:185-194.
59. Samson W.K., Keown C., Samson C.K., Samson H.W., Lane B., Baker J.R., Taylor M.M. Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion. Endocrine 2003, 20:59-66.